Medtronic received a report that the patient had an absence seizure.The patient left from work in a car that they felt they fell asleep and drove a car, however, they do not remember the trip.They were sent to the emergency department.The event was not related to the procedure or study according to the site related assessment.The sponsor assessment determined the event to be possibly related to the pipeline vantage.The adverse event was not related to the patient's disease under study.The event was resolved on (b)(6) 2022.The patient was undergoing surgery for treatment of a saccular aneurysm in the posterior communicating artery with a max diameter of 6mm and a 4mm neck diameter.The patient had significant stasis at the end of the procedure.The patient had complete neck coverage at the end of the procedure.The aneurysm occlusion status at the end of the procedure was class 3 raymond roy.
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|